Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report 2026
Download Free Sample Buy Now
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report 2026

Global Outlook – By Dosage Form (Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms), By Therapeutic Area (Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology), By End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

• Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations market size has reached to $54.73 billion in 2025

• Expected to grow to $90.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%

• Growth Driver: The Growing Drug Development And Manufacturing Activities Is Fueling The Growth Of The Market Due To Rising Demand For Novel Therapeutics And Accelerated Production Timelines

• Market Trend: Advancement Of High-Concentration Biologic Formulation Platforms To Enhance Drug Stability And Delivery Efficiency

• Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

A pharmaceutical contract development and manufacturing organization (CDMO) for formulations refers to a company that provides outsourced services to develop and produce drug formulations for pharmaceutical firms. These services include activities such as formulation development, analytical testing, clinical trial material production, and large-scale commercial manufacturing.

The main types of dosage forms for pharmaceutical contract development and manufacturing organizations (CDMO) for formulations are oral solids, oral liquids, injectables, topicals, inhalation products, transdermals and patches, and others. Oral solid dosage forms are medications taken by mouth, formulated to deliver the drug within the digestive system. It is used in various therapeutic areas such as oncology, cardiology, central nervous system, gastroenterology, infectious diseases, and endocrinology, and is used by several end-users, including pharmaceutical companies, biopharmaceutical companies, and others.

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Global Report 2026 Market Report bar graph

What Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size and Share 2026?

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market size has grown rapidly in recent years. It will grow from $54.73 billion in 2025 to $60.7 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to limited availability of specialized peptide api manufacturers, reliance on in-house peptide production, growing peptide therapeutics pipelines, increasing regulatory compliance requirements, adoption of basic chemical synthesis methods.

What Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Growth Forecast?

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market size is expected to see rapid growth in the next few years. It will grow to $90.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to advancements in custom peptide synthesis technologies, expansion of commercial-scale gmp manufacturing, increasing outsourcing to cros and smes, development of lifecycle management and process optimization strategies, rising demand for clinical and preclinical peptide api manufacturing. Major trends in the forecast period include rising outsourcing of peptide api manufacturing to contract manufacturers, growth in gmp-grade production for clinical and commercial supply, increasing demand for custom peptide synthesis and purification services, expansion of peptide therapeutics pipelines across pharmaceutical companies, focus on process optimization and lifecycle management for peptide apis.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmentation

1) By Dosage Form: Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms

2) By Therapeutic Area: Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology

3) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users

Subsegments:

1) By Oral Solids: Tablets, Capsules, Granules, Powders, Modified-Release Formulations

2) By Oral Liquids: Syrups, Suspensions, Solutions, Emulsions, Elixirs

3) By Injectables: Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions

4) By Topicals: Creams, Ointments, Gels, Lotions, Foams,

5) By Inhalation Products: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules

6) By Transdermal And Patches: Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches

7) By Other Dosage Forms: Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants

What Is The Driver Of The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

The growing drug development and manufacturing activities are expected to propel the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market going forward. Drug development and manufacturing activities refer to the increasing efforts by pharmaceutical and biopharmaceutical companies to research, develop, and produce new drugs. Drug development and manufacturing activities are rising primarily due to the growing global demand for novel and effective therapeutics, which pushes companies to expand their development pipelines and speed up manufacturing timelines. A pharmaceutical CDMO aids drug development by formulating and optimizing dosage forms, performing stability testing, and ensuring regulatory compliance. It also manages scale-up and production, enabling faster, cost-efficient product launches. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for $422,803 million (€390,000 million) in 2023, up from $393,857 million (€363,300 million) in 2022. Therefore, growing drug development and manufacturing activities are driving the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations industry.

Key Players In The Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited.

Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends and Insights

Major companies operating in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market are focusing on developing advanced solutions, such as biologic formulation platforms, to enhance drug stability and accelerate time-to-market for complex biologic therapies. Biologic formulation platforms are specialized systems designed to create stable and efficient formulations of biologic drugs. They fine-tune elements such as pH, excipients, and delivery methods to enhance stability, bioavailability, and safety across the product lifecycle. For instance, in June 2025, WuXi Biologics, a China-based contract research, development, and manufacturing organization, launched WuXiHigh 2.0, a next-generation high-concentration formulation platform. This advanced platform enables biologic formulations with protein concentrations up to 230 mg/mL, surpassing the current Food and Drug Administration-approved maximum of 200 mg/mL, while reducing viscosity by up to 90% through proprietary excipient blends and high-throughput instrumentation. It addresses key challenges in developing high-concentration biologics, such as viscosity and aggregation, and is designed to improve injection efficiency, patient compliance, and manufacturing outcomes across clinical and commercial stages.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

In February 2025, Jabil Inc., a US-based provider of engineering, manufacturing, and supply chain solutions, acquired Pharmaceutics International Inc. (Pii) for an undisclosed amount. The acquisition aims to enhance Jabil’s pharmaceutical manufacturing and development capabilities by leveraging Pii’s expertise in aseptic filling, lyophilization, and oral solid dose production. This strengthens Jabil’s position in parenteral drug delivery and expands its end-to-end support across clinical and commercial manufacturing. Pharmaceutics International Inc. (Pii) is a US-based pharmaceutical contract development and manufacturing organization that provides formulation development services for injectable to oral drug forms.

Regional Insights

Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market consists of revenues earned by entities by providing services such as analytical and stability testing, formulation development, process development and scale-up, regulatory support and documentation, and commercial-scale manufacturing and packaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market also includes sales of suppositories, ophthalmic preparations, buccal and sublingual tablets, liposomal formulations, and microneedle patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report 2026?

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $60.7 billion
Revenue Forecast In 2035 $90.76 billion
Growth Rate CAGR of 10.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Dosage Form, Therapeutic Area, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, A
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Outsourcing Of Peptide Api Manufacturing To Contract Manufacturers

4.2.2 Growth In Gmp-Grade Production For Clinical And Commercial Supply

4.2.3 Increasing Demand For Custom Peptide Synthesis And Purification Services

4.2.4 Expansion Of Peptide Therapeutics Pipelines Across Pharmaceutical Companies

4.2.5 Focus On Process Optimization And Lifecycle Management For Peptide Apis

5. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotech Companies

5.3 Contract Research Organizations (Cros)

5.4 Clinical Research Laboratories

5.5 Academic And Research Institutions

6. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmentation

9.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms

9.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology

9.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users

9.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Capsules, Granules, Powders, Modified-Release Formulations

9.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Syrups, Suspensions, Solutions, Emulsions, Elixirs

9.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions

9.7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Creams, Ointments, Gels, Lotions, Foams

9.8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules

9.9. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches

9.10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants

10. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regional And Country Analysis

10.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

11.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

12.1. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

13.1. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

14.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

15.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

16.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

17.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

18.1. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

19.1. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

20.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

21.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

22.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

23.1. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

24.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

25.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

26.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

27.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

28.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

29.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

30.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

31.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

32.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

33.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

34.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regulatory and Investment Landscape

36. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Company Profiles

36.1. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Other Major And Innovative Companies

Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group

38. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

40. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market High Potential Countries, Segments and Strategies

40.1 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Supply Chain Analysis
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Raw Material Providers
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Resource Providers
  • Table 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Distributors And Channel Partners
  • Table 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Key Technologies & Future Trends
  • Table 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Trends
  • Table 10: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major End Users
  • Table 11: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - TAM, US$ Billion, 2025
  • Table 15: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Company Scoring Matrix
  • Table 101: Thermo Fisher Scientific Inc. Financial Performance
  • Table 102: Lonza Group Financial Performance
  • Table 103: Catalent Inc. Financial Performance
  • Table 104: WuXi Biologics Financial Performance
  • Table 105: Samsung Biologics Financial Performance
  • Table 106: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Competitive Dashboard
  • Table 108: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Table 110: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Table 111: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Supply Chain Analysis
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Raw Material Providers
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Resource Providers
  • Figure 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Distributors And Channel Partners
  • Figure 8: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Key Technologies & Future Trends
  • Figure 9: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major Trends
  • Figure 10: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Major End Users
  • Figure 11: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia , Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Company Scoring Matrix
  • Figure 101: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 102: Lonza Group Financial Performance
  • Figure 103: Catalent Inc. Financial Performance
  • Figure 104: WuXi Biologics Financial Performance
  • Figure 105: Samsung Biologics Financial Performance
  • Figure 106: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Competitive Dashboard
  • Figure 108: Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Figure 110: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Figure 111: Global, Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2026 - Global Outlook – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase ...

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products...

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II...

Pharmaceutical Contract Packaging Market Report 2026 - Global Outlook – By Product (Primary Packaging, Secondary Packaging, Tertiary Packaging ), By Material (Paper And Paperboard, Plastics And Polymers, Aluminum Foil, G...

Pharmaceutical Continuous Manufacturing Market Report 2026 - Global Outlook – By Product (Integrated Continuous System, Control And Software, Semi-Continuous System), By Therapeutics Type (Large Molecule, Small Molecule)...

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAI, And Molecular Therapy, Biosimilars), B...

Fill-Finish Pharmaceutical Contract Manufacturing Market Report 2026 - Global Outlook – By Product Type (Prefilled Syringes, Vials, Cartridges, Other Products), By Molecule Type (Large Molecules, Small Molecules), By End...

Pharmaceutical Logistics Market Report 2026 - Global Outlook – By Type (Cold Chain Logistics, Non-Cold Chain Logistics), By Component (Storage, Transportation, Monitoring Components), By Procedure (Picking, Storage, Retr...

Frequently Asked Questions

The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations market was valued at $54.73 billion in 2025, increased to $60.7 billion in 2026, and is projected to reach $90.76 billion by 2030.

The global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations market is expected to grow at a CAGR of 10.6% from 2026 to 2035 to reach $90.76 billion by 2035.

Some Key Players in the Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations market Include, Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited. .

Major trend in this market includes: Advancement Of High-Concentration Biologic Formulation Platforms To Enhance Drug Stability And Delivery Efficiency. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us